Commentary on prevention a possible drug-drug interaction: Is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity?

Commentary on prevention a possible drug-drug interaction: Is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity?

Background: Drug-drug interactions (DDIs) are an emerging threat to public health and are difficult to detect. To prevent DDIs and their burden, the possible DDIs should be kept in mind. We know that the obesity predisposes to the development of insulin resistance and type 2 diabetes. Therefore, com...

Full description

Bibliographic Details
Main Authors: Marjan Emzhik, Parvaneh Rahimi-Moghaddam, Soltan Ahmad Ebrahimi, Fariborz Keyhanfar, Ashraf Sadat Moazzam
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:International Journal of Preventive Medicine
Subjects:
Drug-drug interaction
human hepatocellular carcinoma cells
liver toxicity
orlistat
pioglitazone
Online Access:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2015;volume=6;issue=1;spage=16;epage=16;aulast=Emzhik

Internet

http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2015;volume=6;issue=1;spage=16;epage=16;aulast=Emzhik

Similar Items